国际医药技术许可与投资平台
Company Id9000952
Company NameHB Human BioScience SAS
Meeting statusRequested
Status
Company typesBiotech or pharma, therapeutic R&DInvestor (buy-side or sell-side research)Biotech or pharma, animal healthMedical device or technologyOther products or servicesBiotech - industrial & environmental
briefSummaryDevelopers, Importers and Distributors of Pharmaceutical Products for Rare or Catastrophic Diseases in Latin America.
DescriptionHB Human BioScience is a pharmaceutical company operating in Colombia, Peru, Ecuador, Venezuela, Mexico, Chile and Panama. Our goal is to provide the patients in our areas with the most advanced and innovative treatments for rare life threatening diseases. To this end we operate under two business models, product development, and in-licensing / Distribution. .Over the years we have teamed up with many global companies such as Galen Limited (UK), Helm AG (Germany), Strides Arcolab (India), AET (Germany), Almac Group (UK), Bharat Serums and Vaccines (India), Orion (Finland), PharmaCept (Germany), and Qilu (China) to in license products for our territories. .Because of this successful licensing strategy we have 32 products on the market with 5 innovator drugs (DaunoXome, Icotinib, Thymogam, EmboCept S, and Peg-Aspargase) and 3 first to market generics (Temozolomide, Exemestane, and Bortezomib). .In addition to our licensing model we also count with a very large infrastructure for named patient sales. This is a service we provide exclusively to our in licensed innovator products (such as Peg-Aspargase and DaunoXome) while registration is completed, this way we can not only start generating sales but also create experience in the medical community for our products. This is something we have been doing for many years now and not only have we found it to be a large revenue booster before the MA is approved but also great marketing tactic to generate knowledge of the products for when the MA is granted. .The complementation of the licensing strategy is our development strategy. Currently we are developing and contract manufacturing 20 products to launch in the market at different stages of development. We have obtained marketing authorizations for 3 of our products: HB Aleos (Injectable Sildenafil 10 Mg), HB Aleos (Sildenafil Tablets for PAH 20 Mg), and Polymiyin B, and have three other products under registration..Because of this combination between In-Licensing and Development our company has grown massively in sales and now sells USD $12,000,000 per year. .We cordially invite you to visit our website www.HBHumanBioScience.com to learn more about our company.
newsHB Human BioScience will be present at BIO in Boston MA, CPHI China in Shanghai China, and DIA Global in Boston MA.
primaryTherapeuticAreasAndrologyGrowth disorderNeoplasmRespiratory diseaseSurgical procedureUlcerCardiovascular tumorPulmonary heart diseaseAdrenal gland hyperfunctionAdrenal gland tumorBreast tumorAdrenal gland tumorMultiple endocrine neoplasiaNeuroendocrine tumorPancreatic endocrine tumorBreast tumorThyroid tumorGonad tumorOsteoporosisOsteopetrosisDiabetes mellitusHypoparathyroidismHyperparathyroidismPineal body diseasePituitary tumorThyroid tumorGastrointestinal tumorGastrointestinal ulcerAplasiaBlood clotting factor deficiencyBlood transfusionBone marrow diseaseAnemiaLeukemiaChronic leukemiaMyeloid leukemiaLymphoid leukemiaAcute leukemiaLymphoblastic leukemiaLymphomaHodgkins diseaseNon-Hodgkin lymphomaMultiple myelomaAutoimmune diseaseGraft versus host diseaseTransplant rejectionBenign tumorCancerMale tumorMetastasisNeoplasm by siteOtorhinolaryngological tumorPrecancerPainGastrointestinal painGenitourinary painNeuropathic painAbdominal painRenal painHeadacheOcular painMyalgiaComplex regional pain syndromeMusculoskeletal pain
secondaryTherapeuticAreas
numberOfEmployees50 to 200
foundedYear2010
OwnershipPrivate
Licensing objectives
Company_objectivesTo provide patients and caregivers in our territory with the most advanced treatment solutions by Developing, In-Licensing, Importing and/or Distributing the latest medicines from around the world.
Ticker
Market_Capitalization
Last rounds of founding
Total Founding
Websitewww.hbhumanbioscience.com
mainEmailjpperez@hbhumanbioscience.com
Phone number+57-1-743-7022, +1-561-389-4165, +1-202-241-8078
CountryColombia
stateDC
CityBogota
AddressCarrera 12 # 96-81
Zip Code110221
createdOn05/16/2018 11:51 PM
modifiedOn05/30/2018 6:13 AM

点击 返回上一页